 OncLive | New Mechanism of Resistance Identified in Brain Tumors - OncLive OncLive “Understanding the mechanisms of acquired resistance is essential for developing more effective treatments for patients that combine mTOR inhibitors with other agents to suppress this resistance,” Mischel said. Investigations into these processes led ... |
